Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2005-001510-40-ES
EUCTR2005-001510-40-ES
Active, not recruiting
Not Applicable

Prospective randomized study to assess the efficacy and tolerability of ferrimannitol ovoalbumin compared to ferrous sulphate in the treatment of iron deficiency anaemia

TEDEC MEIJI FARMA, S.A.0 sitesMay 16, 2006
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsIron deficiency anaemia
DrugsProfer 40 mg GranuladoFero-gradumet

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Iron deficiency anaemia
Sponsor
TEDEC MEIJI FARMA, S.A.
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 16, 2006
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
TEDEC MEIJI FARMA, S.A.

Eligibility Criteria

Inclusion Criteria

  • •Patients \> 18 years old
  • •Diagnosis of iron deficiency anaemia
  • •Informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Anaemia not related with iron deficiency
  • •Pregnancy and lactation
  • •Diseases with iron overload
  • •Patients who have received iron treatment within the previous 3 months prior to the inclusion in the study.
  • •Digestive pathology that may cause intolerance or malabsortion
  • •Hepatic insufficiency
  • •Chronic pancreatitis
  • •Renal insufficiency
  • •AIDS or seropositive patients, infection, neoplasia or continuos haemorrhage

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Randomized Evaluation of the effectiveness in terms of reduction of cerebral ischemia in patients undergoing carotid angioplasty load of different doses of clopidogrel (300vs600mg) and high-dose atorvastati
EUCTR2011-005330-18-ITIVERSITA' CAMPUS BIOMEDICO150
Completed
Not Applicable
Prospective randomized trial to assess the efficacy of 0.5% Marcaine subserosal injection in the gall bladder fossa to reduce the post operative pain from laparoscopic cholecystectomySigns and Symptoms: PainSigns and SymptomsPain
ISRCTN68753145Record Provided by the NHSTCT Register - 2006 Update - Department of Health50
Not yet recruiting
Not Applicable
A Study To Evaluate Benefit and Risk Between Two Different Dose Schedule Of Internal Radiation Treatment In Cancer Cervix PatientsHealth Condition 1: C531- Malignant neoplasm of exocervix
CTRI/2023/04/051952SVIMS
Completed
Not Applicable
To assess the efficacy and tolerability of three antimalarial treatments in The Democratic Republic of Congo (DRC)MalariaInfections and InfestationsPlasmodium falciparum malaria
ISRCTN20984426The Centre for Tropical Medicine (UK)684
Active, not recruiting
Phase 1
A study to investigate the efficacy and safety of L19TNF in previously treated patients with advanced stage or metastatic soft-tissue sarcoma
EUCTR2018-004104-19-DEPhilogen S.p.A.98